Dr. Baumann is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 Biscayne Blvd
Ste 101
Miami, FL 33137Phone+1 305-532-5552Fax+1 305-534-5224
Education & Training
- University of Miami/Jackson Health SystemResidency, Dermatology, 1994 - 1997
- Baylor College of MedicineInternship, Transitional Year, 1993 - 1994
- Baylor College of MedicineClass of 1993
Certifications & Licensure
- CA State Medical License 2006 - 2026
- FL State Medical License 1997 - 2026
- TX State Medical License 1994 - 2026
- NY State Medical License 2003 - 2025
- American Board of Dermatology Dermatology
- National Board of Physicians and Surgeons Dermatology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- Dose Response Study of Patients With Erythematous Rosacea Start of enrollment: 2010 Aug 01
- Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds Start of enrollment: 2010 Sep 27
- Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea Start of enrollment: 2011 May 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsWITHDRAWN: Efficacy and safety of topical oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 2 phase 3, 29...Linda Stein-Gold, Leon H Kircik, Zoe Diane Draelos, Philip Werschler, Janet DuBois
Journal of the American Academy of Dermatology. 2018-02-04 - 31 citationsEfficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trialZoe Diana Draelos, Michael H. Gold, Robert Weiss, Leslie Baumann, Steven Grekin
Journal of the American Academy of Dermatology. 2018-06-01 - 11 citationsEfficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: A phase II, randomized, controlled, double-blinded trialBrandon Kirsch, Stacy Smith, Joel L. Cohen, Janet DuBois, Lawrence Green
Journal of the American Academy of Dermatology. 2020-06-01
Authored Content
- Dermatologists’ Role in the Development of the Skin Care IndustryOctober 2020
Press Mentions
- The Best Eczema Creams of 2021, According to DermatologistsOctober 6th, 2021
- Gut Microbiome’s Key Role in Aging and LongevityJuly 1st, 2021
- 6 Skin-Care Ingredient Combinations That Don’t MixFebruary 13th, 2020
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: